Patients with high deductible health plans aren’t getting the imaging they need.
Patients who have insurance plans with high deductibles tend to undergo fewer imaging tests than patients without plans, according to a study published online in Medical Care.
Researchers from the Boston University Questrom School of Business, the School of Public Health and Health Sciences at University of Massachusetts Amherst, and Massachusetts
Institute of Technology (MIT) Sloan School of Management in Cambridge, sought to evaluate and quantify associations between enrollment in high deductible health plans (HDHP) enrollment and the use of diagnostic imaging, such as MRI, X-rays, and CT scans, nationally in all health care settings.
Using commercial insurance claims data of over 21 million individuals from 2010, the researchers made comparisons between use of diagnostic imaging tests and standardized payments between patients in HDHPs and non-HDHPs. To be considered a high deductible plan, the annual deductible had to be at least $1,200 for individuals and $2,400 for families.
The results showed that enrollment in HDHPs was associated with a 7.5% decrease in the number of imaging studies for patients, and a 10.2% decrease in standardized imaging payments. Those patients in HDHPs were 1.7% less likely to undergo imaging, although the difference was small once a patient underwent at least one imaging study.[[{"type":"media","view_mode":"media_crop","fid":"45011","attributes":{"alt":"Kimberley Geissler, PhD","class":"media-image media-image-right","id":"media_crop_141545019506","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"5080","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 215px; width: 170px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"Kimberley Geissler, PhD","typeof":"foaf:Image"}}]]
"I think what we found most surprising is the large reductions in imaging use among people with high deductibles,” senior author Kimberley Geissler, PhD, assistant professor of health policy and management at the School of Public Health and Health Sciences at UMass Amherst, said in a release. “We had hoped to find that patients were reducing use of low-value imaging, but we found they reduced all use similarly. It seems patients are not informed enough to discern which tests are more optional and which are medically necessary."
The researchers concluded that plans with high deductibles may actually be barriers, reducing access to some diagnostic imaging, including high-value imaging compared with low-value tests. “Better patient awareness and education may be a crucial part of any reductions in diagnostic imaging utilization,” they wrote.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.